Brief: Innate Pharma FY Net Loss Narrows To 52.8 Million Euros

Innate Pharma SA

24/03/2022 06:34

March 24 (Reuters) - Innate Pharma SA  IPH.PA :
    * INNATE PHARMA REPORTS FULL YEAR 2021 FINANCIAL RESULTS AND
BUSINESS UPDATE
    * CASH POSITION OF EUR 159.7 MILLION AS OF DECEMBER 31, 2021
    * THE COMPANY’S PROPRIETARY TETRA-SPECIFIC ANKETTM IPH65 IS
PROGRESSING TO IND ENABLING STUDIEs
    * AS OF DECEMBER 31, 2021, FINANCIAL LIABILITIES AMOUNT TO
€44.3M
(€19.1M AS OF DECEMBER 31, 2020)
    * REVENUE AND OTHER INCOME FROM CONTINUING OPERATIONS
AMOUNTED TO
EUR 24.7M IN 2021 (2020: EUR 69.8M, -64.6%)
    * FY A NET FINANCIAL INCOME OF €2.3M IN 2021 (2020: €1.9M
LOSS)
    * NET LOSS OF EUR 52.8M IN 2021 (2020: NET LOSS OF EUR
64.0M)

Source text for Eikon:  urn:newsml:reuters.com:*:nBw2Kz2HJa
Further company coverage:  IPH.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 772 09 20;))